GLIALOGIX INC has a total of 17 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals are NANJING ZHONGKE GROUP CO LTD, HEGLUND A S and INTEXIM S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Reeder Thaddeus Cromwell | 12 |
#2 | Moore Mark Wade | 11 |
#3 | Lyon David Keith | 11 |
#4 | Lorenz Douglas Alan | 11 |
#5 | Moore Mark W | 4 |
#6 | Lyon David K | 4 |
#7 | Lorenz Doug | 4 |
#8 | Bloom Corey | 4 |
#9 | Jager Casey K | 4 |
#10 | Shepard Kimberly | 3 |
Publication | Filing date | Title |
---|---|---|
TW201818933A | Compositions and methods for the treatment of neurodegenerative and other diseases | |
WO2014121137A2 | Compositions and methods for the treatment of neurodegenerative and other diseases |